Centenara Labs, formerly Rejuveron, rebrands to focus on anti-ageing research
FiercePharma - 23-Sep-2024Their lead treatment, EA-2353, shows promising safety results for retinitis pigmentosa
Rejuveron
Company that develops and invests in drugs and technologies which prolong human lifespan.
Rejuveron is an integrated biotechnology platform company that develops and improves therapies and technologies to promote healthy aging and prolong lifespan.
We are a dynamic team of experienced drug discovery and development experts, building a new Incubator lab space at the Bio-Technopark in Schlieren (Zurich).
We provide start-up coaching and funding to entrepreneurial scientists to co-create therapies that benefit our aging population.
Visit website: https://rejuveron.com/en/
Details last updated 18-Dec-2020
Rejuveron News
Rejuveron raises $20 million for Endogena to advance treatment for eye diseases
CISION PR Newswire - 31-Dec-2021Funds to develop regenerative therapies for retinitis pigmentosa and advanced age-related macular degeneration
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021More and more companies making greater and greater progress - 2021 could be an exciting year
Rejuveron Creations
Rejuveron Age Better Live Longer Symposium
10-May-2022
Symposium about healthy living organized by Rejuveron (FREE)
People at Rejuveron
Matthias Steger
Biotech Entrepreneur and co-founder and Chief Executive Officer at Endogena Therapeutics
